Preventing contrast nephropathy in catheter laboratory
- PMID: 17502647
- PMCID: PMC1955216
- DOI: 10.1136/hrt.2006.107714
Preventing contrast nephropathy in catheter laboratory
Abstract
See article on page 698
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.Heart. 2007 Jun;93(6):698-702. doi: 10.1136/hrt.2006.097477. Epub 2006 Oct 25. Heart. 2007. PMID: 17065180 Free PMC article. Clinical Trial.
References
-
- Alwall N, Erlanson P, Tornberg A. This clinical course of renal failure occurring after intravenous urography and/or retrograde pyelography; casuistics of 11 cases (including 7 deaths); on indications for and risks involved in the use of contrast media, including some remarks on the risk of aspiration biopsy of the kidney. Acta Med Scand 955 152163–173. - PubMed
-
- Chertow G M, Christiansen C L, Cleary D P. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 19951551505–1511. - PubMed
-
- Murphy S W, Barrett B J, Parfrey P S. Contrast nephropathy. J Am Soc Nephrol 200011177–182. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical